Your browser doesn't support javascript.
COVID-19: the difference between the nose and the lung.
Gelardi, Matteo; Notargiacomo, Mario; Trecca, Eleonora Maria Consiglia; Cassano, Michele; Ciprandi, Giorgio.
  • Gelardi M; Department of Otolaryngology, University of Foggia. gelardim@inwind.it.
  • Notargiacomo M; Otorhinolaryngology Unit, Melzo Hospital, Milan. Mario.notargiacomo@gmail.com.
  • Trecca EMC; Department of Otolaryngology, University of Foggia. Eleonora.trecca@unifg.it.
  • Cassano M; Department of Otolaryngology, University of Foggia. Michele.cassano@unifg.it.
  • Ciprandi G; Allergy Clinic, Casa di Cura Villa Montallegro, Genoa. gio.cip@libero.it.
Monaldi Arch Chest Dis ; 91(2)2021 Mar 05.
Article in English | MEDLINE | ID: covidwho-1119588
ABSTRACT
To the Editor An elegant study reported dysmorphic cells and syncytia in the deceased's lungs for COVID-19. The authors reasonably considered that most of these syncytia-forming cells were pneumocytes, as identified by specific biomarkers. However, cellular dysmorphism and syncytia are pathological features common in other respiratory infections caused by different viruses, including the human respiratory syncytial virus (HRSV) and Epstein-Barr virus (EBV), as correctly documented...
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nose / COVID-19 / Lung Limits: Humans Language: English Year: 2021 Document Type: Article

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Nose / COVID-19 / Lung Limits: Humans Language: English Year: 2021 Document Type: Article